The current landscape of adipose-derived stem cells in clinical applications

Expert Reviews in Molecular Medicine

Volumn 16, Issue , 2014, Pages

  Lim, Ming Hui ^a   Ong, Wee Kiat ^a   Sugii, Shigeki ^a,b  

^a AGENCY FOR SCIENCE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE;

ADIPOSE DERIVED STEM CELL; BIOREACTOR; BONE GRAFT; BONE REGENERATION; CARCINOGENICITY; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL ISOLATION; DIABETES MELLITUS; EUROPEAN UNION; FISTULA; GOOD MANUFACTURING PRACTICE; GOVERNMENT REGULATION; GRAFT VERSUS HOST REACTION; HEART INFARCTION; HUMAN; INJECTABLE IMPLANT; LIPOSUCTION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSTEOARTHRITIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RECONSTRUCTIVE SURGERY; REVIEW; SKULL DEFECT; SKULL FRACTURE; SOUTH KOREA; STEM CELL CULTURE; STROMAL VASCULAR FRACTION; TISSUE ENGINEERING; TISSUE REGENERATION; UNITED STATES; WOUND HEALING; ADULT STEM CELL; ANIMAL; BONE; CARDIOVASCULAR DISEASE; CARTILAGE; CELL SEPARATION; CYTOLOGY; LEGAL ASPECT; MESENCHYMAL STROMA CELL; PHYSIOLOGY; REGENERATION; TRANSPLANTATION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ADULT STEM CELLS; ANIMALS; BONE AND BONES; CARDIOVASCULAR DISEASES; CARTILAGE; CELL SEPARATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; REGENERATION;

EID: 84906931889     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/erm.2014.8     Document Type: Review

References (145)

1. Zuk, P. A., et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering 7, 211-228
2. Gimble, J. M., Katz, A. J. and Bunnell, B. A. (2007) Adipose-derived stem cells for regenerative medicine. Circulation Research 100, 1249-1260
3. Bourin, P., et al. (2013) Stromal cells fromthe adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15, 641-648
4. Dominici, M., et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317
5. Strem, B. M. and Hedrick, M. H. (2005) The growing importance of fat in regenerative medicine. Trends in Biotechnology 23, 64-66
6. Schäffler, A. and Büchler, C. (2007) Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 25, 818-827
7. Lindroos, B., Suuronen, R. and Miettinen, S. (2011) The potential of adipose stem cells in regenerative medicine. Stem Cell Reviews and Reports 7, 269-291
8. Fraser, J., et al. (2008) Adipose-derived stem cells. In Mesenchymal Stem Cells (Prockop D., Bunnell B. and Phinney D. eds, Center for Gene Therapy, Tulane University Health Science Center), Humana Press: New York, USA, pp. 59-67.
9. Carvalho, P. P., et al. (2013) Xenofree enzymatic products for the isolation of human adiposederived stromal/stem cells. Tissue Engineering C, Methods 19, 473-478
10. Bianchi, F., et al. (2013) A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transplantation 22, 2063-2077
11. Shah, F. S., et al. (2013) A non-enzymatic method for isolating human adipose tissue-derived stromal stem cells. Cytotherapy 15, 979-985
12. Francis, M. P., et al. (2010) Isolating adipose-derived mesenchymal stem cells from lipoaspirate blood and saline fraction. Organogenesis 6, 11-14
13. Yoshimura, K., et al. (2006) Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. Journal of Cellular Physiology 208, 64-76
14. Kim, I. H., et al. (2009) Evaluation of centrifugation technique and effect of epinephrine on fat cell viability in autologous fat injection. Aesthetic Surgery Journal 29, 35-39
15. Kurita, M., et al. (2008) Influences of centrifugation on cells and tissues in liposuction aspirates: optimized centrifugation for lipotransfer and cell isolation. Plastic and Reconstructive Surgery 121, 1033-1041
16. Sterodimas, A. (2011) Adipose stem cell engineering: clinical applications in plastic and reconstructive surgery. In Adipose Stem Cells and Regenerative Medicine (Illouz Y.-G. and Sterodimas A. eds), pp. 165-179, Springer, Berlin, Heidelberg
17. Lee, R. H., et al. (2004) Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cellular Physiology and Biochemistry 14, 311-324
18. Gstraunthaler, G. (2003) Alternatives to the use of fetal bovine serum: serum-free cell culture. Altex 20, 275-281
19. Will, R. G., et al. (1996)Anew variant of Creutzfeldt-Jakob disease in the UK. The Lancet 347, 921-925
20. Heiskanen, A., et al. (2007) N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25, 197-202
21. Kocaoemer, A., et al. (2007) Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25, 1270-1278
22. Kakudo, N., et al. (2008) Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plastic and Reconstructive Surgery 122, 1352-1360
23. Johansson, L., et al. (2003) Platelet lysate: a replacement for fetal bovine serum in animal cell culture? Cytotechnology 42, 67-74
24. Mirabet, V., et al. (2008) Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Cell and Tissue Banking 9, 1-10
25. Kim, S. J., et al. (2005) Human adipose stromal cells expanded in human serum promote engraftment of human peripheral blood hematopoietic stem cells in NOD/SCID mice. Biochemical and Biophysical Research Communications 329, 25-31
26. Lindroos, B., et al. (2009) Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro. Cytotherapy 11, 958-972
27. Rajala, K., et al. (2010) A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One 5, e10246
28. Santos, F. d., et al. (2011) Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. Tissue Engineering C, Methods 17, 1201-1210
29. Lund, P., et al. (2009) Effect of growth media and serum replacements on the proliferation and differentiation of adipose-derived stem cells. Cytotherapy 11, 189-197
30. Martin, I., Smith, T. and Wendt, D. (2009) Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products. Trends in Biotechnology 27, 495-502
31. Güven, S., et al. (2012) Validation of an automated procedure to isolate human adipose tissue-derived cells by using the Sepax® Technology. Tissue Engineering C, Methods 18, 575-582
32. Lin, K., et al. (2008) Characterization of adipose tissue-derived cells isolated with the Celution™ system. Cytotherapy 10, 417-426
33. Boriani, F., Warr, R. andAscione, R. (2011) Industrial approaches to adipose stem cells engineering. In Adipose Stem Cells and Regenerative Medicine (Illouz Y.-G. and Sterodimas A. eds), p. 245-255, Springer, Berlin, Heidelberg
34. Thirumala, S., Goebel, W. S. and Woods, E. J. (2009) Clinical grade adult stem cell banking. Organogenesis 5, 143-154
35. Liseth, K., et al. (2005) The viability of cryopreserved PBPC depends on the DMSOconcentration and the concentration of nucleated cells in the graft. Cytotherapy 7, 328-333
36. Benekli, M., et al. (2000) Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone MarrowTransplantation 25, 1299
37. Windrum, P. and Morris, T. (2003) Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplantation 31, 315-315
38. Sharpless, N. E. and DePinho, R. A. (2007) How stem cells age and why this makes us grow old. Nature Reviews Molecular Cell Biology 8, 703-713
39. Schipper, B. M., et al. (2008) Regional anatomic and age effects on cell function of human adipose derived stem cells. Annals of Plastic Surgery 60, 538-544
40. van Harmelen, V., Röhrig, K. and Hauner, H. (2004) Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism 53, 632-637
41. van Harmelen, V., et al. (2003) Effect of BMI and age on adipose tissue cellularity and differentiation capacity inwomen. International Journal of Obesity 27, 889-895
42. Jurgens, W. J., et al. (2008) Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell and Tissue Research 332, 415-426
43. Aust, L., et al. (2004) Yield of human adiposederived adult stem cells from liposuction aspirates. Cytotherapy 6, 7-14
44. Pettersson, P., et al. (1985) Adipocyte precursor cells in obese and nonobese humans. Metabolism 34, 808-812
45. Kim, H. K., et al. (2008) Alterations in the proangiogenic functions of adipose tissue-derived stromal cells isolated from diabetic rats. Stem Cells and Development 17, 669-680
46. Hauner, H. and Entenmann, G. (1991) Regional variation of adipose differentiation in cultured stromal-vascular cells from the abdominal and femoral adipose tissue of obese women. International Journal of Obesity 15, 121
47. Oedayrajsingh-Varma, M., et al. (2006) Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissueharvesting procedure. Cytotherapy 8, 166-177
48. Mason, C., et al. (2011) Cell therapy industry: billion dollar global business with unlimited potential. Regenerative Medicine 6, 265-272
49. Kellathur, S. N. and Lou, H.-X. (2012) Cell and tissue therapy regulation: worldwide status and harmonization. Biologicals 40, 222-224
50. Sensebe, L., et al. (2010) Mesenchymal stem cells for clinical application. Vox Sanguinis 98, 93-107
51. Antunes, M. and Pottering, H. (2007) Regulation (EC) No 1394/2007 of The European Parliament and of The Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. Journal of European Union L 324, 121-137
52. Liras, A. (2010) Future research and therapeutic applications of human stem cells: general, regulatory., bioethical aspects. Journal of Translational Medicine 8, 131
53. Oh, I.-H. (2012) Regulatory issues in stem cell therapeutics in Korea: efficacy or efficiency? The Korean Journal of Hematology 47, 87-89
54. Wohn, D. Y. (2012) Korea okays stem cell therapies despite limited peer-reviewed data. Nature Medicine 18, 329-329
55. Ong, W. K. and Sugii, S. (2013) Adipose-derived stem cells: fatty potentials for therapy. The International Journal of Biochemistry & Cell Biology 45, 1083-1086
56. Sridhar, P., et al. (2012) Adipose-derived regenerative cells for the treatment of patients with non-revascularisable ischaemic cardiomyopathy-the PRECISE Trial. Interventional Cardiology 7, 77-80
57. Houtgraaf, J. H., et al. (2012) First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology 59, 539-540
58. Qayyum, A. A., et al. (2012) Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. Regenerative Medicine 7, 421-428
59. Lee, H., et al. (2012) Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia. Circulation Journal 76, 1750-1760
60. Herreros, M., et al. (2012) Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation. Diseases of the Colon & Rectum 55, 762-772
61. Garcia-Olmo, D., et al. (2009) Expanded adiposederived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Diseases of the Colon & Rectum 52, 79-86
62. Portilla, F., et al. (2013) Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial. International Journal of Colorectal Disease 28, 313-323
63. Ra, J. C., et al. (2011) Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells and Development 20, 1297-1308
64. Lendeckel, S., et al. (2004) Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. Journal of Cranio-Maxillofacial Surgery 32, 370-373
65. Thesleff, T., et al. (2011) Cranioplasty with adiposederived stem cells and biomaterial: a novel method for cranial reconstruction. Neurosurgery 68, 1535
66. Mesimäki, K., et al. (2009) Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. International Journal of Oral and Maxillofacial Surgery 38, 201-209
67. Gimble, J. M., Guilak, F. and Bunnell, B. A. (2010) Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Research Therapy 1, 19
68. Pak, J. (2012) Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecroticfemoralheads. PainPhysician15, 75-85
69. Pak, J. (2011) Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissuederived stem cells: a case series. Journal of Medical Case Reports 5, 1-8
70. Rada, T., Reis, R. L. and Gomes, M. E. (2009) Adipose tissue-derived stem cells and their application in bone and cartilage tissue engineering. Tissue Engineering B, Reviews 15, 113-125
71. Mann, D. L. (1999) Mechanisms and models in heart failure: a combinatorial approach. Circulation 100, 999-1008
72. Valina, C., et al. (2007) Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion., remodelling after acute myocardial infarction. European Heart Journal 28, 2667-77
73. Alt, E., et al. (2010) Effect of freshly isolated autologous tissue resident stromal cells on cardiac function and perfusion following acute myocardial infarction. International Journal of Cardiology 144, 26-35
74. Ii, M., et al. (2010) Synergistic effect of adiposederived stem cell therapy and bone marrow progenitor recruitment in ischemic heart. Laboratory Investigation 91, 539-552
75. Schenke-Layland, K., et al. (2009) Adipose tissuederived cells improve cardiac function following myocardial infarction. Journal of Surgical Research 153, 217-223
76. Miyahara, Y., et al. (2006) Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Medicine 12, 459-465
77. Nian, M., et al. (2004) Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research 94, 1543-1553
78. Nakagami, H., et al. (2005) Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arteriosclerosis, Thrombosis., Vascular Biology 25, 2542-2547
79. Moon, M. H., et al. (2006) Human adipose tissuederived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cellular Physiology and Biochemistry 17, 279-290
80. Rehman, J., et al. (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109, 1292-1298
81. Traktuev, D. O., et al. (2009) Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circulation Research 104, 1410-1420
82. Planat-Benard, V., et al. (2004) Plasticity of human adipose lineage cells toward endothelial cells. Circulation 109, 656-663
83. Miranville, A., et al. (2004) Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110, 349-355
84. Traktuev, D. O., et al. (2008) A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location., stabilize endothelialnetworks. CirculationResearch102, 77-85
85. Tabit, C. J., et al. (2012) Fat grafting versus adiposederived stem cell therapy: distinguishing indications, techniques., outcomes. Aesthetic Plastic Surgery 36, 704-713
86. Yoshimura, K., et al. (2008) Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plastic Surgery 32, 48-55
87. Sterodimas, A., et al. (2010) Cell-assisted lipotransfer. Aesthetic Surgery Journal 30, 78-81
88. Matsumoto, D., et al. (2006) Cell-assisted lipotransfer: supportive use of human adiposederived cells for soft tissue augmentation with lipoinjection. Tissue Engineering 12, 3375-3382
89. Sterodimas, A., et al. (2011) Autologous fat transplantation versus adipose-derived stem cell-enriched lipografts a study. Aesthetic Surgery Journal 31, 682-693
90. Calabrese, C., et al. (2009) Breast reconstruction after nipple/areola-sparing mastectomy using cellenhanced fat grafting. Ecancermedicalscience 3, 116
91. Yoshimura, K., et al. (2008) Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells. Dermatologic Surgery 34, 1178-1185
92. Yoshimura, K., et al. (2010) Progenitor-enriched adipose tissue transplantation as rescue for breast implant complications. The Breast Journal 16, 169-175
93. Kamakura, T. and Ito, K. (2011) Autologous cellenriched fat grafting for breast augmentation. Aesthetic Plastic Surgery 35, 1022-1030
94. Pérez-Cano, R., et al. (2012) Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial. European Journal of Surgical Oncology 38, 382-389
95. KIM, M., et al. (2011) Clinical trial of autologous differentiated adipocytes from stem cells derived from human adipose tissue. Dermatologic Surgery 37, 750-759
96. Tiryaki, T., Findikli, N. and Tiryaki, D. (2011) Staged stem cell-enriched tissue (SET) injections for soft tissue augmentation in hostile recipient areas: a preliminary report. Aesthetic Plastic Surgery 35, 965-971
97. Koh, K. S., et al. (2012) Clinical application of human adipose tissue-derived mesenchymal stem cells in progressive hemifacial atrophy (parry-romberg disease) with microfat grafting techniques using 3-dimensional computed tomography and 3-dimensional camera. Annals of Plastic Surgery 69, 331-337
98. Altman, A. M., et al. (2009) IFATS collection: human adipose-derived stem cells seeded on a silk fibroinchitosan scaffold enhance wound repair in a murine soft tissue injury model. Stem Cells 27, 250-258
99. Kim, W.-S., et al. (2007) Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. Journal of Dermatological Science 48, 15-24
100. Lin, Y.-C., et al. (2013) Evaluation of a multi-layer adipose-derived stem cell sheet in a full-thickness wound healing model. Acta Biomaterialia 9, 5243-5250
101. Maharlooei, M. K., et al. (2011) Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats. Diabetes Research and Clinical Practice 93, 228-234
102. Nie, C., et al. (2011) Locally administered adiposederived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplantation 20, 205-216
103. Jackson, W. M., Nesti, L. J. and Tuan, R. S. (2012) Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Translational Medicine 1, 44-50
104. Kim, W.-S., Park, B.-S. and Sung, J.-H. (2009) The wound-healing and antioxidant effects of adiposederived stem cells. Expert Opinion on Biological Therapy 9, 879-887
105. Akita, S., et al. (2010) Noncultured autologous adipose-derived stem cells therapy for chronic radiation injury. Stem Cells International 2010(Article ID 532704), 8
106. Akita, S., et al. (2012) Autologous adipose-derived regenerative cells are effective for chronic intractable radiation injuries. Radiation Protection Dosimetry 151, 656-660
107. Sung, H. M., et al. (2012) Case reports of adiposederivedstemcell therapyfornasalskinnecrosisafter filler injection. Archives of Plastic Surgery 39, 51-54
108. Cervelli, V., et al. (2010) Tissue regeneration in loss of substance on the lower limbs through use of platelet-rich plasma, stem cells from adipose tissue., hyaluronic acid. Advances in Skin & Wound Care 23, 262
109. Rigotti, G., et al. (2007) Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adiposederived adult stem cells. Plastic and Reconstructive Surgery 119, 1409-1422
110. Lin, C.-S., Lin, G. and Lue, T. F. (2012) Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells and Development 21, 2770-2778
111. Griffin, M. D., Ritter, T. and Mahon, B. P. (2010) Immunological aspects of allogeneic mesenchymal stem cell therapies. Human Gene Therapy 21, 1641-1655
112. Fang, B. and Song, Y. (2006) Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stemcells. BoneMarrowTransplantation 38, 389-390
113. Fang, B., et al. (2007) Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplantation Proceedings 39, 3358-3362
114. Fang, B., et al. (2007) Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children. Pediatric Transplantation 11, 814-817
115. Fang, B., et al. (2007) Using human adipose tissuederived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis. Transplantation Proceedings 39, 1710-1713
116. Fang, B., et al. (2007) Treatment of resistant pure red cell aplasia after major abo-incompatible bone marrow transplantation with human adipose tissue-derived mesenchymal stem cells. American Journal of Hematology 82, 772-773
117. Fang, B., et al. (2009) Resolution of refractory chronic autoimmune thrombocytopenic purpura following mesenchymal stem cell transplantation: a case report. Transplantation Proceedings 41, 1827-1830
118. Le Blanc, K., et al. (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scandinavian Journal of Immunology 57, 11-20
119. Garcia-Olmo, D., Garcia-Arranz, M. and Herreros, D. (2008) Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease. Expert Opinion on Biological Therapy 8, 1417-1423
120. Garcia-Olmo, D., et al. (2009) Treatment of enterocutaneous fistula in Crohn's disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. International Journal ofColorectal Disease 24, 27-30
121. McIntosh, K., et al. (2006) The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 24, 1246-1253
122. Vanikar, A., et al. (2010) Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus. Stem Cells International 2010(Article ID 582382), 5
123. Garciá-Olmo, D., et al. (2003) Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. International Journal of Colorectal Disease 18, 451-454
124. Garciá-Olmo, D., et al. (2005) A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Diseases of the Colon & Rectum 48, 1416-1423
125. Guadalajara, H., et al. (2012) Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. International Journal of Colorectal Disease 27, 595-600
126. de la Portilla, F., et al. (2012) Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial. International Journal of Colorectal Disease, 28, 313-323, 1-11
127. Casiraghi, F., et al. (2013) Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem Cell Reviews and Reports 9, 65-79
128. Klopp, A. H., et al. (2011) Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells 29, 11-19
129. Prockop, D. J., et al. (2010) Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 12, 576-578
130. Rubio, D., et al. (2005) Spontaneous human adult stem cell transformation. Cancer Research 65, 3035-3039
131. Garcia, S., et al. (2010) Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Experimental Cell Research 316, 1648
132. Vaquero, J. and Zurita, M. (2013) Cell transplantation in paraplegic patients: the importance of properly assessing the spinal cord morphology. Clinical Transplantation 27, 968-971
133. Martin-Rendon, E., et al. (2008) Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. European Heart Journal 29, 1807-1818
134. Riordan, N. H., et al. (2009) Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. Journal of Translational Medicine 7, 1-9
135. Ichim, T. E., et al. (2010) Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease. Cellular Immunology 264, 7-17
136. Ra, J. C., et al. (2011) Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. Journal of Translational Medicine 9, 181
137. Galie, M., et al. (2007) Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Oncogene 27, 2542-2551
138. Lucia, K., et al. (2010) Tumor cell behaviour modulation by mesenchymal stromal cells. Molecular Cancer 9, 129
139. Muehlberg, F. L., et al. (2009) Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 30, 589-597
140. Prantl, L., et al. (2010) Adipose tissue-derived stem cells promote prostate tumor growth. The Prostate 70, 1709-1715
141. Yu, J. M., et al. (2008)Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells and Development 17, 463-474
142. Zimmerlin, L., et al. (2010) Regenerative therapyand cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Engineering A 17, 93-106
143. Lin, G., et al. (2010) Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. The Prostate 70, 1066-1073
144. Cousin, B., et al. (2009) Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS One 4, e6278
145. Zhu, Y., et al. (2009)Humanmesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 23, 925-933